American Portfolios Advisors Blueprint Medicines Corp Transaction History
American Portfolios Advisors
- $2.36 Trillion
- Q3 2022
A detailed history of American Portfolios Advisors transactions in Blueprint Medicines Corp stock. As of the latest transaction made, American Portfolios Advisors holds 10 shares of BPMC stock, worth $1,149. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10Holding current value
$1,149% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding BPMC
# of Institutions
352Shares Held
60.7MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$768 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$764 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$619 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$456 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$318 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.86B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...